Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-02-09 @ 9:07 AM
Study NCT ID:
NCT03050060
Status:
TERMINATED
Last Update Posted:
2022-06-22
First Post:
2017-02-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-12
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-08
First Submit QC Date:
None
Study First Post Date:
2017-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-22
Results First Submit QC Date:
None
Results First Post Date:
2022-06-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-06-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-05-26
Last Update Post Date:
2022-06-22
Last Update Post Date Type:
ACTUAL